Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3375 of 6351
-
Strasbourg hospital staff antibody study reveals infection spread
Knowledge-focused CompletedCOVID-19 is a new emerging disease caused by infection with the SARS-CoV-2 coronavirus, with no specific therapeutic options. Since the end of February 2020, the Strasbourg University Hospital (HUS) had faced a sudden increase of patients with COVID-19 resulted from a SARS-CoV-2…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Ebola survivors under the microscope: what happens after recovery?
Knowledge-focused CompletedEbola virus is one of the most dangerous human pathogens and is an emerging public health problem in sub-Saharan Africa. Ebola virus disease (EVD) first appeared in 1976. The current epidemic in the Democratic Republic of the Congo (DRC) is one of the largest and most complex eve…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
New pain block may reduce opioid use in kids after hip surgery
Symptom relief CompletedSurgical repair of the hip can be extremely painful and is associated with considerable postoperative pain in children despite the use of systemic opioids. These patients may benefit from neuraxial analgesia in adjunction with general anesthesia. The reported advantages of this t…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Aug 13, 2026 00:00 UTC
-
Lung cancer & COVID: new study tracks immune response in nearly 2,000 patients
Knowledge-focused CompletedObservational, retrospective data collection and prospective IgG analysis, and multicenter study. The main objective of the study is th description of the characteristics and evolution of patients with lung cancer who have acquired COVID-19 infection. For the identification of …
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Video therapy boosts autism communication at home
Symptom relief CompletedThere is an urgent need for improved access to effective autism treatments. With advances in technology, distance learning models have particular promise for families who cannot access evidence-based parent training locally or may be on long wait-lists for behavioral treatments. …
Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Kefir peptides show promise for fracture healing in small study
Disease control CompletedThis study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone formation and reduce inflammation. Participants with recent upper limb fractures will…
Sponsor: Jen-Chieh Lai • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for Tough-to-Treat myeloma: early safety trial of HPN217 begins
Disease control OngoingResearchers want to learn if MK-4002 (also known as HPN217) can treat relapsed or refractory multiple myeloma (RRMM). The goals of this study are to learn about the safety of different doses of MK-4002 and how well people tolerate them. Researchers also want to learn what happens…
Phase 1 • Sponsor: Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Cancer combo trial halted before full results
Disease control Stopped earlyAn ascending dose study in patients with solid tumors to evaluate the safety, tolerability, pharmacodynamics and efficacy of APG-1387 in combination with toripalimab. A phase II study of 3 cohorts will be included.
Phase 1/2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New hope for essential thrombocythemia patients: experimental drug targets overactive platelet production
Disease control OngoingThis is a single-center, open-label investigator-initiated trial evaluating the effects of IMG-7289 administered orally once daily in patients with essential thrombocythemia.
Phase 2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 26, 2026 15:31 UTC
-
COVID-19's skin secrets: could chilblains hold clues to the virus?
Knowledge-focused Recruiting nowSome patients infected by covid-19 develop skin manifestations. These manifestations are still not well known and there pathophysiology remain unclear. Among them, acral manifestation resembling to chilblains appears frequent and quite specific. The aim of this project is to bett…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Experimental COVID-19 drug shows promise in tiny trial
Disease control CompletedA randomized, open-label, 2 arm, pilot trial of Lambda 180 mcg administered subcutaneously once weekly, for up to two weeks (2 injections at most), in addition to standard supportive care, compared to standard supportive care alone, in a population of COVID-19 infected patients. …
Phase 2 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Cialis and keytruda together against head and neck cancer: small trial shows promise?
Disease control CompletedThis study will examine the combination of pembrolizumab and tadalafil for safety and efficacy in advanced head and neck cancer.
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can early liver transplants save lives in alcoholic hepatitis? new study aims to find out
Knowledge-focused By invitation onlyThe purpose of this study is to develop a clinical understanding of early liver transplantation (ELT) for patients with severe alcoholic hepatitis (SAH) and identify the public's opinion regarding this practice.
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
MitoQ trial targets MS fatigue – a new hope for tired patients?
Symptom relief CompletedThe purpose of this study is to determine whether MS patients who receive Oral mitoquinone (MitoQ) have less fatigue than those receiving a placebo. A comparison between patient's fatigue scored at baseline and fatigue scored 12 weeks after drug initiation will assess if MitoQ ha…
Phase 1/2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a magnetic helmet boost brainpower in Parkinson's?
Symptom relief Recruiting nowThe purpose of this study is to examine safety, feasibility, and the behavioral and brain effects of a non-invasive treatment, repetitive transcranial magnetic stimulation (rTMS), for Veterans with Parkinson's disease or atypical parkinsonism and mild impairments in their thinkin…
Phase 1/2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Which filling lasts longer in Kids' weak enamel? a Head-to-Head trial
Disease control CompletedThis study evaluated the clinical performances of a glass hybrid restoration and direct posterior micro-hybrid composite restorations with short fiber reinforced composite (SFRC) after Selective Caries Removal in restorations of first permanent molars (FPMs) that were affected by…
Sponsor: Marmara University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Experimental COM902 drug shows promise in early cancer trial
Disease control CompletedPhase 1 open label sequential dose escalation and cohort expansion study evaluating the safety, tolerability and preliminary antitumor activity of COM902 as monotherapy and in combination with COM701 in subjects with advanced malignancies.
Phase 1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New drug combo shows promise for blood cancer patients
Disease control OngoingThe purpose of this study is to determine the safety, tolerability; and to define the maximum tolerated dose (MTD) and Recommended Phase 2 Dose (RP2D); and to evaluate the safety and tolerability of the ramp-up dosing schedule and at the RP2D of BGB-11417 monotherapy, and when gi…
Phase 1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New MRI technique may spot brain tumor return vs. radiation scar
Diagnosis Recruiting nowThis trial uses magnetic resonance elastography (MRE) to estimate tissue stiffness (hardness or softness of the tissue) in tissue that is affected by radiation treatment (radiation necrosis) and tumor tissue that has come back (recurrent) after treatment in patients with gliomas.…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New study tracks best ways to treat hemophilia a when standard therapy fails
Knowledge-focused Recruiting nowThis is a non-interventional, multicenter, observational, international study in male persons with haemophilia A who have developed inhibitors to any replacement coagulation factor VIII (FVIII) product. The purpose of the study is to capture different approaches in the management…
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:08 UTC